Hyun Ho Chung is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his work on imidazole derivatives. With a total of five patents to his name, Chung's innovations are paving the way for advancements in medical treatments.

Latest Patents

Chung's latest patents focus on imidazole derivatives that exhibit inhibitory activity for farnesyl transferase. The first patent describes novel imidazole derivatives, including pharmaceutically acceptable salts or isomers, and pharmaceutical compositions that incorporate these compounds. The invention also details intermediate compounds used in the preparation of these imidazole derivatives. The second patent further elaborates on a specific imidazole derivative represented by a defined formula, along with the processes for its preparation and the intermediates involved. This work highlights Chung's commitment to developing effective pharmaceutical solutions.

Career Highlights

Hyun Ho Chung is currently employed at LG Chemical Ltd., where he continues to innovate and contribute to the field of chemical engineering and pharmaceuticals. His work has garnered attention for its potential impact on drug development and therapeutic applications.

Collaborations

Chung collaborates with notable colleagues, including Jong Sung Koh and Hyun Il Lee. Their combined expertise enhances the research and development efforts within their organization.

Conclusion

Hyun Ho Chung's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to advancing medical science. His work on imidazole derivatives is a testament to the importance of research and collaboration in developing new therapeutic options.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com